Philippe Schafhausen

Dr. Philippe Schafhausen is a Physician Scientist specializing in Hematology and Oncology at the University Medical Center Hamburg-Eppendorf (UKE). He serves in the II. Medical Clinic and Polyclinic and contributes to the University Cancer Center Hamburg (UCCH). His clinical focus includes myeloid neoplasms, head and neck cancers, and targeted cancer therapies.

His research examines tyrosine kinase inhibitor therapies for chronic myeloid leukemia, immunotherapy approaches for solid tumors, and clinical trial design. Recent publications explore cancer vaccine efficacy, molecular mechanisms of treatment resistance, and consensus guidelines for sinonasal tumor management. Research themes include:

• Optimizing TKI regimens for CML patients
• Novel immunotherapies for squamous cell carcinomas
• Management strategies for therapy-resistant malignancies

Publications show consistent focus on translational oncology, with recent emphasis on PD-1/PD-L1 inhibitors and combinatorial treatment approaches. Clinical trials demonstrate expertise in phase 2 study design and biomarkers for treatment response.